The Association for Clinical Oncology (ASCO) has signed on to a joint letter to Congressional leaders about the impact of potential Medicaid cuts on access to cancer care for children. Led by the ...

The Association for Clinical Oncology (ASCO) is one of nearly 50 specialty groups urging the National Institutes of Health (NIH) to rescind a recent policy change limiting how much research ...

The American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS) are hosting a webinar to help oncology professionals gain actionable strategies for implementing sustainable ...

The Conquer Cancer Patient Advocate Award Program helps patient advocates attend ASCO Meetings to learn of important advances in their areas of interest. As of July 2024, more than 1,150 patient ...

To continue, please click on one of the buttons below or access other content through the navigation menu or search.

Thank you for your interest in the ASCO Plenary Series. Effective June 2024, the Series will pause indefinitely and is not accepting abstract submissions. With greatly increased demand for in-person ...

Multivariate model and incidence of VTE by MCS score. Incidence of VTE by MCS Score ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris ...

ALEXANDRIA, Va. – Nine studies exploring new approaches for the treatment of genitourinary cancers will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Genitourinary ...

“The TALAPRO-2 study showed a significant improvement in overall survival in men with mCRPC treated with the combination of talazoparib and enzalutamide whether they had HRR gene alterations. In this ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 14, 2025, the Food and Drug Administration approved vimseltinib (Romvimza, ...

The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...